|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.7 TWD | +0.65% |
|
-0.26% | +5.16% |
DIVA Laboratories, Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 712.23 million compared to TWD 736.93 million a year ago. Net income was TWD 21.86 million compared to TWD 17.42 million a year ago.
Basic earnings per share from continuing operations was TWD 0.37 compared to TWD 0.26 a year ago. Diluted earnings per share from continuing operations was TWD 0.37 compared to TWD 0.26 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.16% | 70.19M | |
| +15.57% | 30.08B | |
| +5.81% | 11.61B | |
| +2.48% | 4.33B | |
| -13.17% | 4.05B | |
| -16.25% | 3.93B | |
| +17.04% | 3.92B | |
| -4.20% | 3.84B | |
| -27.51% | 2.64B | |
| -20.50% | 1.66B |
DIVA LABORATORIES, LTD. 
